Scheriderm Diflucortolone Isoconazole & Neomycin Cream 15 g


Please consult your physician before taking any medication. Dosage form 1 g of cream contains 1 mg (0.1%) diflucortolone valerate, 10 mg (1.0%) isoconazole nitrate and 5 mg (0.5%) of neomycin sulfate. INDICATIONS All dermatosis responsive to topical corticosteroid therapy and are affected by bacterial and / or fungal. • Dermatitis secondarily infected by bacteria and / or fungi: nummular eczema, seborrheic eczema, dyshidrotic eczema, eczema if varicose syndrome (except direct employment leg ulcers), bactéride, eczemátide. • Bacterial infections with marked inflammatory symptoms: pyoderma (folliculitis, impetigo), erythrasma. • Dermatomycoses caused by dermatophytes, yeasts and fungi levulimorfos (tinea, candidiasis, pityriasis versicolor) when inflammatory manifestations or secondary eczematization occupy the foreground. CONTRAINDICATIONS Tuberculosis or syphilitic processes in the area being treated, viral diseases (eg., Chickenpox, herpes zoster), rosacea, perioral dermatitis and skin reactions following immunization in the treatment area. Hypersensitivity to the active substances or to any of the excipients. DOSAGE AND ADMINISTRATION As a rule, the treatment is begun by applying SCHERIDERM ® thin layer 2 or 3 times daily, depending on the severity of the case. Initiated clinical improvement, usually just one application a day. In the infectious dermatitis and / or fungal, inflammation disappeared once and if necessary can continue treatment with antimicrobial prepared without corticosteroid. In infants and children under 4 years of treatment should be maintained for more than three weeks, especially in areas covered by the diaper. PRESENTATIONS SCHERIDERM ® Tubes with 15 g. (Reg. San. No: 27.115-06-06)

Reviews Scheriderm Diflucortolone Isoconazole & Neomycin Cream 15 g

Leave your review